Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation

Frontiers in Immunology

Volumn 5, Issue JUL, 2014, Pages

  Felton, Jennifer M ^a   Lucas, Christopher D ^a   Rossi, Adriano G ^a   Dransfield, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Airway; Allergy; Apoptosis; Eosinophil; Inflammation; Lung; Phagocytosis; Resolution

Indexed keywords

EID: 84905669404     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00302     Document Type: Review

References (139)

1. Meagher LC, Cousin JM, Seckl JR, Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol (1996) 156:4422-8.
2. Savill J, Wyllie A, Henson J, Walport M, Henson P, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 83:865. doi: 10.1172/JCI113970
3. Juncadella IJ, Kadl A, Sharma AK, Shim YM, Hochreiter-Hufford A, Borish L. Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature (2012) 493:547-51. doi:10.1038/nature11714
4. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 13:159-75. doi:10.1038/nri3399
5. Peters A. Just how big is the pulmonary granulocyte pool? Clin Sci (1998) 94:7-19.
6. Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol (2010) 31:318-24. doi:10.1016/j.it.2010.05.006
7. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol (2002) 2:965-75. doi:10.1038/nri957
8. Gabelloni ML, Trevani AS, Sabatté J, Geffner J. Mechanisms regulating neutrophil survival and cell death. Semin Immunopathol (2013) 35(4):423-37. doi:10.1007/s00281-013-0364-x
9. Galluzzi L, Vitale I, Abrams J, Alnemri E, Baehrecke E, Blagosklonny M, et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2012) 19:107-20. doi:10.1038/cdd.2011.96
10. Woodfin A, Voisin M-B, Beyrau M, Colom B, Caille D, Diapouli F-M. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat Immunol (2011) 12:761-9. doi:10.1038/ni.2062
11. Robertson AL, Holmes GR, Bojarczuk AN, Burgon J, Loynes CA, Chimen M. A zebrafish compound screen reveals modulation of neutrophil reverse migration as an anti-inflammatory mechanism. Sci Transl Med (2014) 6:225ra29. doi:10.1126/scitranslmed.3007672
12. Lucas CD, Hoodless LJ, Rossi AG. Swimming against the tide: drugs drive neutrophil reverse migration. Sci Transl Med (2014) 6:225fs9. doi:10.1126/scitranslmed.3008666
13. Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, Kozlowski E. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med (2008) 14:949-53. doi:10.1038/nm.1855
14. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy (2008) 38:709-50. doi:10.1111/j.1365-2222.2008.02958.x
15. Gleich G, Flavahan N, Fujisawa T, Vanhoutte P. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol (1988) 81:776-81. doi:10.1016/0091-6749(88)90931-1
16. Venge P, Peterson G. Epithelial injury by human eosinophils-3. Am Rev Respir Dis (1988) 138:S54-7.
17. Ueki S, Melo RC, Ghiran I, Spencer LA, Dvorak AM, Weller PF. Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans. Blood (2013) 121:2074-83. doi:10.1182/blood-2012-05-432088
18. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol (1992) 148:3543-9.
19. Ilmarinen P, Kankaanranta H. Eosinophil apoptosis as a therapeutic target in allergic asthma. Basic Clin Pharmacol Toxicol (2014) 114:109-17. doi:10.1111/bcpt.12163
20. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 35:495-516. doi:10.1080/01926230701320337
21. Knight DA, Holgate ST. The airway epithelium: structural and functional properties in health and disease. Respirology (2003) 8:432-46. doi:10.1046/j.1440-1843.2003.00493.x
22. Liu X, Driskell RR, Engelhardt JF. Airway glandular development and stem cells. Curr Top Dev Biol (2004) 64:33-56. doi:10.1016/S0070-2153(04)64003-8
23. Jeffery P. Morphologic features of airway surface epithelial cells and glands. Am Rev Respir Dis (1983) 128:S14.
24. Rawlins EL, Hogan BL. Epithelial stem cells of the lung: privileged few or opportunities for many? Development (2006) 133:2455-65. doi:10.1242/dev.02407
25. MacNee W. ABC of chronic obstructive pulmonary disease: pathology, pathogenesis, and pathophysiology. BMJ (2006) 332:1202. doi:10.1136/bmj.332.7551.1202
26. Sidhu MK, Mandal P, Hill AT. Bronchiectasis: an update on current pharmacotherapy and future perspectives. Expert Opin Pharmacother (2014) 15:505-25. doi:10.1517/14656566.2014.878330
27. Duffin R, Leitch AE, Fox S, Haslett C, Rossi AG. Targeting granulocyte apoptosis: mechanisms, models, and therapies. Immunol Rev (2010) 236:28-40. doi:10.1111/j.1600-065X.2010.00922.x
28. Parfrey H, Farahi N, Porter L, Chilvers ER. Live and let die: is neutrophil apoptosis defective in severe asthma? Thorax (2010) 65:665-7. doi:10.1136/thx.2009.134270
29. Brown V, Elborn JS, Bradley J, Ennis M. Dysregulated apoptosis and NFkappaB expression in COPD subjects. Respir Res (2009) 10:10.1186. doi:10.1186/1465-9921-10-24
30. Cole P. Host-microbe relationships in chronic respiratory infection. Respiration (1989) 55:5-8. doi:10.1159/000195745
31. Barnes PJ, Stockley R. COPD: current therapeutic interventions and future approaches. Eur Respir J (2005) 25:1084-106. doi:10.1183/09031936.05.00139104
32. Casaburi R, Mahler D, Jones P, Wanner A, San Pedro G, ZuWallack R. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J (2002) 19:217-24. doi:10.1183/09031936.02.00269802
33. Kawashima K, Fujii T. The lymphocytic cholinergic system and its biological function. Life Sci (2003) 72:2101-9. doi:10.1016/S0024-3205(03)00068-7
34. ten Hacken NH, Wijkstra PJ, Kerstjens HA. Treatment of bronchiectasis in adults. BMJ (2007) 335:1089. doi:10.1136/bmj.39384.657118.80
35. Maris NA, de Vos AF, Dessing MC, Spek CA, Lutter R, Jansen HM. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med (2005) 172:878-84. doi:10.1164/rccm.200503-451OC
36. Dowling RB, Rayner C, Rutman A, Jackson AD, Kanthakumar K, Dewar A. Effect of salmeterol on Pseudomonas aeruginosa infection of respiratory mucosa. Am J Respir Crit Care Med (1997) 155:327-36. doi:10.1164/ajrccm.155.1.9001332
37. Dowling R, Johnson M, Cole P, Wilson R. Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro. Eur Respir J (1998) 11:86-90. doi:10.1183/09031936.98.11010086
38. Park YM, Bochner BS. Eosinophil survival and apoptosis in health and disease. Allergy Asthma Immunol Res (2010) 2:87-101. doi:10.4168/aair.2010.2.2.87
39. Bousquet J, Chanez P, Lacoste JY, Barnéon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med (1990) 323:1033-9. doi:10.1056/NEJM199010113231505
40. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis (1989) 139:806-17. doi:10.1164/ajrccm/139.3.806
41. Hastie A, Loegering D, Gleich G, Kueppers F. The effect of purified human eosinophil major basic protein on mammalian ciliary activity. Am Rev Respir Dis (1987) 135:848-53.
42. Flavahan N, Slifman N, Gleich G, Vanhoutte P. Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle: role of the epithelium. Am Rev Respir Dis (1988) 138:685-8. doi:10.1164/ajrccm/138.3.685
43. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, O'Neill KR. Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 305:1773-6. doi:10.1126/science.1099472
44. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE. A critical role for eosinophils in allergic airways remodeling. Science (2004) 305:1776-9. doi:10.1126/science.1100283
45. Chung KF, Barnes PJ. Treatment of asthma. Br Med J (Clin Res Ed) (1987) 294:103. doi:10.1136/bmj.294.6564.103
46. Wood AJ, Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med (1999) 340:197-206. doi:10.1056/NEJM199905133401907
47. Menzies-Gow A, Ying S, Sabroe I, Stubbs VL, Soler D, Williams TJ, et al. Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early-and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol (2002) 169:2712-8. doi:10.4049/jimmunol.169.5.2712
48. Gonzalo J-A, Lloyd CM, Kremer L, Finger E, Martinez-A C, Siegelman M. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest (1996) 98:2332. doi:10.1172/JCI119045
49. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol (1993) 8:349-55. doi:10.1165/ajrcmb/8.4.349
50. Rot A, Krieger M, Brunner T, Bischoff SC, Schall T, Dahinden C. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med (1992) 176:1489-95. doi:10.1084/jem.176.6.1489
51. Bischoff SC. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol (2007) 7:93-104. doi:10.1038/nri2018
52. Tsai M, Grimbaldeston M, Galli SJ. Mast cells and immunoregulation/immunomodulation. In: Gilfillan AM, Metcalfe DD, editors. Mast Cell Biology (Vol. 716). Springer: Bethesda, MD (2011). p. 186-211.
53. Karra L, Berent-Maoz B, Ben-Zimra M, Levi-Schaffer F. Are we ready to downregulate mast cells? Curr Opin Immunol (2009) 21:708-14. doi:10.1016/j.coi.2009.09.010
54. Wechsler JB, Hsu C-L, Bryce PJ. IgE-mediated mast cell responses are inhibited by thymol-mediated, activation-induced cell death in skin inflammation. J Allergy Clin Immunol (2014) 133(6):1735-43. doi:10.1016/j.jaci.2013.12.024
55. Richards DF, Fernandez M, Caulfield J, Hawrylowicz CM. Glucocorticoids drive human CD8+ T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur J Immunol (2000) 30:2344-54. doi:10.1002/1521-4141(2000)30:8<2344::AID-IMMU2344>3.0.CO;2-7
56. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci (2004) 1024:138-46. doi:10.1196/annals.1321.010
57. Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol (1999) 162:3639-46.
58. McColl A, Bournazos S, Franz S, Perretti M, Morgan BP, Haslett C. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol (2009) 183:2167-75. doi:10.4049/jimmunol.0803503
59. Wang J, Wang C, Li X, Kong L, Gao K, Liu R-Y. The effects of anti-asthma drugs on the phagocytic clearance of apoptotic eosinophils by A549 cells. Respir Med (2009) 103:1693-9. doi:10.1016/j.rmed.2009.05.014
60. Sivertson KL, Seeds MC, Long DL, Peachman KK, Bass DA. The differential effect of dexamethasone on granulocyte apoptosis involves stabilization of Mcl-1L in neutrophils but not in eosinophils. Cell Immunol (2007) 246:34-45. doi:10.1016/j.cellimm.2007.05.003
61. Ullman A, Svedmyr N. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax (1988) 43:674-8. doi:10.1136/thx.43.9.674
62. Löfdahl CG, Svedmyr N. Formoterol fumarate, a new ß2-adrenoceptor agonist. Allergy (1989) 44:264-71.
63. Waldeck B. ß-Adrenoceptor agonists and asthma - 100 years of development. Eur J Pharmacol (2002) 445:1-12. doi:10.1016/S0014-2999(02)01728-4
64. Krawiec ME, Jarjour NJ. Leukotriene receptor antagonists. Semin Respir Crit Care Med (2002) 23(4):399-410. doi:10.1055/s-2002-34333
65. Lee E, Robertson T, Smith J, Kilfeather S. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med (2000) 161:1881-6. doi:10.1164/ajrccm.161.6.9907054
66. Finney M, Karlsson JA, Persson C. Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. Br J Pharmacol (1985) 85:29-36. doi:10.1111/j.1476-5381.1985.tb08827.x
67. Persson CG. Overview of effects of theophylline. J Allergy Clin Immunol (1986) 78:780-7. doi:10.1016/0091-6749(86)90061-8
68. Adachi T, Motojima S, Hirata A, Fukuda T, Kihara N, Kosaku A, et al. Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5. J Allergy Clin Immunol (1996) 98:S207-15. doi:10.1016/S0091-6749(96)70068-4
69. Yasui K, Hu B, Nakazawa T, Agematsu K, Komiyama A. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibition. J Clin Invest (1997) 100:1677. doi:10.1172/JCI119692
70. Lim S, Tomita K, Carramori G, Jatakanon A, Oliver B, Keller A. Low-dose theophylline reduces eosinophilic inflammation but not exhaled nitric oxide in mild asthma. Am J Respir Crit Care Med (2001) 164:273-6. doi:10.1164/ajrccm.164.2.2006043
71. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol (2013) 131:636-45. doi:10.1016/j.jaci.2012.12.1564
72. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet (2006) 368:804-13. doi:10.1016/S0140-6736(06)69290-8
73. Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med (2006) 12:1056-64. doi:10.1038/nm1206-1434
74. Leitch AE, Riley NA, Sheldrake TA, Festa M, Fox S, Duffin R. The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis. Eur J Immunol (2010) 40:1127-38. doi:10.1002/eji.200939664
75. Leitch A, Haslett C, Rossi A. Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents. Br J Pharmacol (2009) 158:1004-16. doi:10.1111/j.1476-5381.2009.00402.x
76. Alessandri AL, Duffin R, Leitch AE, Lucas CD, Sheldrake TA, Dorward DA. Induction of eosinophil apoptosis by the cyclin-dependent kinase inhibitor AT7519 promotes the resolution of eosinophil-dominant allergic inflammation. PLoS One (2011) 6:e25683. doi:10.1371/journal.pone.0025683
77. Villunger A, O'Reilly LA, Holler N, Adams J, Strasser A. FAS ligand, Bcl-2, granulocyte colony-stimulating factor, and p38 mitogen-activated protein kinase regulators of distinct cell death and survival pathways in granulocytes. J Exp Med (2000) 192:647-58. doi:10.1084/jem.192.5.647
78. Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN. NF-?B activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem (1999) 274:4309-18. doi:10.1074/jbc.274.21.14956
79. Duffin R, Leitch AE, Sheldrake TA, Hallett JM, Meyer C, Fox S. The CDK inhibitor, R-roscovitine, promotes eosinophil apoptosis by down-regulation of Mcl-1. FEBS Lett (2009) 583:2540-6. doi:10.1016/j.febslet.2009.07.017
80. Lee A, Whyte M, Haslett C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol (1993) 54:283-8.
81. Dick EP, Prince LR, Prestwich EC, Renshaw SA, Whyte MK, Sabroe I. Pathways regulating lipopolysaccharide-induced neutrophil survival revealed by lentiviral transduction of primary human neutrophils. Immunology (2009) 127:249-55. doi:10.1111/j.1365-2567.2008.02949.x
82. Gellersen B, Brosens J. Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol (2003) 178:357-72. doi:10.1677/joe.0.1780357
83. Martin MC, Dransfield I, Haslett C, Rossi AG. Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J Biol Chem (2001) 276:45041-50. doi:10.1074/jbc.M105197200
84. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol (1995) 154:4719-25.
85. Fujihara S, Ward C, Dransfield I, Hay RT, Uings IJ, Hayes B, et al. Inhibition of nuclear factor-?B activation un-masks the ability of TNF-a to induce human eosinophil apoptosis. Eur J Immunol (2002) 32:457-66. doi:10.1002/1521-4141(200202)32:2<457::AID-IMMU457>3.0.CO;2-1
86. Vago JP, Nogueira CR, Tavares LP, Soriani FM, Lopes F, Russo RC. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol (2012) 92:249-58. doi:10.1189/jlb.0112008
87. Marwick JA, Dorward DA, Lucas CD, Jones KO, Sheldrake TA, Fox S. Oxygen levels determine the ability of glucocorticoids to influence neutrophil survival in inflammatory environments. J Leukoc Biol (2013) 94:1285-92. doi:10.1189/jlb.0912462
88. Perretti M, D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol (2009) 9:62-70. doi:10.1038/nri2470
89. Solito E, Kamal A, Russo-Marie F, Buckingham JC, Marullo S, Perretti M. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J (2003) 17(11):1544-6.
90. Scannell M, Flanagan MB, Wynne KJ, Cagney G, Godson C, Maderna P. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol (2007) 178:4595-605. doi:10.4049/jimmunol.178.7.4595
91. Maderna P, Yona S, Perretti M, Godson C. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac2-26. J Immunol (2005) 174:3727-33. doi:10.4049/jimmunol.174.6.3727
92. Perretti M, Flower RJ. Annexin 1 and the biology of the neutrophil. J Leukoc Biol (2004) 76:25-9. doi:10.1189/jlb.1103552
93. Cheung P, Wong C, Ip W, Lam C. IL-25 regulates the expression of adhesion molecules on eosinophils: mechanism of eosinophilia in allergic inflammation. Allergy (2006) 61:878-85. doi:10.1111/j.1398-9995.2006.01102.x
94. Suzukawa M, Koketsu R, Iikura M, Nakae S, Matsumoto K, Nagase H. Interleukin-33 enhances adhesion, CD11b expression and survival in human eosinophils. Lab Invest (2008) 88:1245-53. doi:10.1038/labinvest.2008.82
95. Wong CK, Hu S, Cheung PF, Lam CW. Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol (2010) 43:305-15. doi:10.1165/rcmb.2009-0168OC
96. Walsh GM. Eosinophil apoptosis and clearance in asthma. J Cell Death (2013) 6:17-25. doi:10.4137/JCD.S10818
97. Garcia G, Taillé C, Laveneziana P, Bourdin A, Chanez P, Humbert M. Anti-interleukin-5 therapy in severe asthma. Eur Respir Rev (2013) 22:251-7. doi:10.1183/09059180.00004013
98. Bainton DF, Ullyot JL, Farquhar MG. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow origin and content of azurophil and specific granules. J Exp Med (1971) 134:907-34. doi:10.1084/jem.134.4.907
99. Dibbert B, Daigle I, Braun D, Schranz C, Weber M, Blaser K, et al. Role for Bcl-xL in delayed eosinophil apoptosis mediated by granulocyte-macrophage colony-stimulating factor and interleukin-5. Blood (1998) 92:778-83.
100. Lucas C, Dorward D, Tait M, Fox S, Marwick J, Allen K. Downregulation of Mcl-1 has anti-inflammatory pro-resolution effects and enhances bacterial clearance from the lung. Mucosal Immunol (2014) 7(4):857-68. doi:10.1038/mi.2013.102
101. Lucas CD, Allen KC, Dorward DA, Hoodless LJ, Melrose LA, Marwick JA. Flavones induce neutrophil apoptosis by down-regulation of Mcl-1 via a proteasomal-dependent pathway. FASEB J (2013) 27:1084-94. doi:10.1096/fj.12-218990
102. Leitch A, Lucas C, Marwick J, Duffin R, Haslett C, Rossi A. Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation. Cell Death Differ (2012) 19:1950-61. doi:10.1038/cdd.2012.80
103. Sharma S, Dorward DA, Rossi AG, Lucas CD. Wogonin induces caspase-dependent human eosinophil apoptosis. Proceedings of the British Pharmacological Society Online (Vol 11) (2013). Available from: http://www.pa2online.org/abstracts/vol11issue3abst013p.pdf
104. Nutku E, Aizawa H, Hudson SA, Bochner BS. Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood (2003) 101:5014-20. doi:10.1182/blood-2002-10-3058
105. Nutku E, Hudson SA, Bochner BS. Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury. Biochem Biophys Res Commun (2005) 336:918-24. doi:10.1016/j.bbrc.2005.08.202
106. Zimmermann N, McBride M, Yamada Y, Hudson S, Jones C, Cromie K. Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy (2008) 63:1156-63. doi:10.1111/j.1398-9995.2008.01709.x
107. Faustino L, Fonseca D, Florsheim E, Resende R, Lepique A, Faquim-Mauro E. Tumor necrosis factor-related apoptosis-inducing ligand mediates the resolution of allergic airway inflammation induced by chronic allergen inhalation. Mucosal Immunol (2014). doi:10.1038/mi.2014.9
108. Dorward DA, Lucas CD, Allen KC, Rossi AG. Resolution of allergic inflammation. In: Middleton's Allergy Principles and Practice (Vol. 1). Philadelphia: Elsevier Saunders (2013). p. 389-96.
109. Lee CH. Resolvins as new fascinating drug candidates for inflammatory diseases. Arch Pharm Res (2012) 35:3-7. doi:10.1007/s12272-012-0121-z
110. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol (2008) 8:349-61. doi:10.1038/nri2294
111. Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem (1997) 272:6972-8. doi:10.1074/jbc.272.49.30993
112. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol (2000) 164:1663-7. doi:10.4049/jimmunol.164.4.1663
113. Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, Berlasconi G. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol (2002) 13:2497-507. doi:10.1097/01.ASN.0000032417.73640.72
114. Lee TH, Horton CE, Kyan-Aung U, Haskard D, Crea AE, Spur BW. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin Sci (1989) 77:195-203.
115. Bandeira-Melo C, Bozza PT, Diaz BL, Cordeiro RS, Jose PJ, Martins MA. Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J Immunol (2000) 164:2267-71. doi:10.4049/jimmunol.164.5.2267
116. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med (2000) 192:1197-204. doi:10.1084/jem.192.3.F5
117. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature (2007) 447:869-74. doi:10.1038/nature05877
118. Levy BD, Kohli P, Gotlinger K, Haworth O, Hong S, Kazani S. Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol (2007) 178:496-502. doi:10.4049/jimmunol.178.1.496
119. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4. Nat Med (2002) 8:1018-23. doi:10.1038/nm748
120. Haworth O, Cernadas M, Yang R, Serhan CN, Levy BD. Resolvin E1 regulates interleukin 23, interferon-? and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol (2008) 9:873-9. doi:10.1038/ni.1627
121. Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol (2014) 14(3):166-80. doi:10.1038/nri3607
122. Rothlin CV, Lemke G. TAM receptor signaling and autoimmune disease. Curr Opin Immunol (2010) 22:740-6. doi:10.1016/j.coi.2010.10.001
123. Giles KM, Ross K, Rossi AG, Hotchin NA, Haslett C, Dransfield I. Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J Immunol (2001) 167:976-86. doi:10.4049/jimmunol.167.2.976
124. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature (2001) 411:207-11. doi:10.1038/35079659
125. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med (2002) 196:135-40. doi:10.1084/jem.20012094
126. Muñoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 6:280-9. doi:10.1038/nrrheum.2010.46
127. Lu Q, Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science (2001) 293:306-11. doi:10.1126/science.1061663
128. Lauber K, Keppeler H, Munoz L, Koppe U, Schröder K, Yamaguchi H. Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids. Cell Death Differ (2013) 20:1230-40. doi:10.1038/cdd.2013.82
129. Lee Y-J, Han J-Y, Byun J, Park H-J, Park E-M, Chong YH. Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and NF-?B activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury. J Leukoc Biol (2012) 91:921-32. doi:10.1189/jlb.0611289
130. Choi J-Y, Park H-J, Lee Y-J, Byun J, Youn Y-S, Choi JH. Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation. J Pharmacol Exp Ther (2013) 344:447-58. doi:10.1124/jpet.112.199778
131. Gonzalez NA, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity (2009) 31:245-58. doi:10.1016/j.immuni.2009.06.018
132. Zizzo G, Hilliard BA, Monestier M, Cohen PL. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol (2012) 189:3508-20. doi:10.4049/jimmunol.1200662
133. Heasman SJ, Giles KM, Rossi AG, Allen JE, Haslett C, Dransfield I. Interferon ? suppresses glucocorticoid augmentation of macrophage clearance of apoptotic cells. Eur J Immunol (2004) 34:1752-61. doi:10.1002/eji.200324698
134. Thorp E, Vaisar T, Subramanian M, Mautner L, Blobel C, Tabas I. Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cd, and p38 mitogen-activated protein kinase (MAPK). J Biol Chem (2011) 286:33335-44. doi:10.1074/jbc.M111.263020
135. Lee Y-J, Lee S-H, Youn Y-S, Choi J-Y, Song K-S, Cho M-S. Preventing cleavage of Mer promotes efferocytosis and suppresses acute lung injury in bleomycin treated mice. Toxicol Appl Pharmacol (2012) 263:61-72. doi:10.1016/j.taap.2012.05.024
136. Monks J, Rosner D, Geske FJ, Lehman L, Hanson L, Neville M. Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ (2005) 12:107-14. doi:10.1038/sj.cdd.4401517
137. Kirsch T1, Woywodt A, Beese M, Wyss K, Park JK, Erdbruegger U, et al. Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses. Blood (2007) 109(7):2854-62.
138. Sexton DW, Blaylock MG, Walsh GM. Human alveolar epithelial cells engulf apoptotic eosinophils by means of integrin-and phosphatidylserine receptor-dependent mechanisms: a process upregulated by dexamethasone. J Allergy Clin Immunol (2001) 108:962-9. doi:10.1067/mai.2001.119414
139. Walsh GM, Sexton DW, Blaylock MG, Convery CM. Resting and cytokine-stimulated human small airway epithelial cells recognize and engulf apoptotic eosinophils. Blood (1999) 94:2827-35